335 related articles for article (PubMed ID: 15557798)
1. ATM and genome maintenance: defining its role in breast cancer susceptibility.
Khanna KK; Chenevix-Trench G
J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):247-62. PubMed ID: 15557798
[TBL] [Abstract][Full Text] [Related]
2. The genetic epidemiology of breast cancer genes.
Thompson D; Easton D
J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):221-36. PubMed ID: 15557796
[TBL] [Abstract][Full Text] [Related]
3. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
[TBL] [Abstract][Full Text] [Related]
4. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
Zhang N; Che J; Bai S; Wu Z; Cui Y; Zou W
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):9-15. PubMed ID: 20353086
[TBL] [Abstract][Full Text] [Related]
5. [Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].
Tie Y; Mao JP; Liu B; Song Y; Dong Y; Sun ZX
Ai Zheng; 2004 May; 23(5):487-92. PubMed ID: 15142440
[TBL] [Abstract][Full Text] [Related]
6. Atm and cellular response to DNA damage.
Lavin MF; Kozlov S; Gueven N; Peng C; Birrell G; Chen P; Scott S
Adv Exp Med Biol; 2005; 570():457-76. PubMed ID: 18727511
[No Abstract] [Full Text] [Related]
7. Association of common ATM polymorphism with bilateral breast cancer.
Heikkinen K; Rapakko K; Karppinen SM; Erkko H; Nieminen P; Winqvist R
Int J Cancer; 2005 Aug; 116(1):69-72. PubMed ID: 15756685
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
[TBL] [Abstract][Full Text] [Related]
9. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
10. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
11. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
[TBL] [Abstract][Full Text] [Related]
13. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative ATM mutations in breast cancer families.
Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
[TBL] [Abstract][Full Text] [Related]
16. Rare variants in the ATM gene and risk of breast cancer.
Goldgar DE; Healey S; Dowty JG; Da Silva L; Chen X; Spurdle AB; Terry MB; Daly MJ; Buys SM; Southey MC; Andrulis I; John EM; ; ; Khanna KK; Hopper JL; Oefner PJ; Lakhani S; Chenevix-Trench G
Breast Cancer Res; 2011 Jul; 13(4):R73. PubMed ID: 21787400
[TBL] [Abstract][Full Text] [Related]
17. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
18. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
Hall J
Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
[TBL] [Abstract][Full Text] [Related]
19. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
20. A multifaceted role for ATM in genome maintenance.
Pandita TK
Expert Rev Mol Med; 2003 Jun; 5(16):1-21. PubMed ID: 14987398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
